\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ surgical\\ resection\\ with\\ continued\\ follow\\ up\\ to\\ monitor\\ for\\ residual\\ or\\ recurrent\\ tumor\\.\ \(0\)\
\-\ there\\ is\\ a\\ smoothly\\ marginated\\,\\ extra\\-axial\\ mass\\ which\\ is\\ located\\ along\\ the\\ root\\ entry\\ zone\\ of\\ the\\ trigeminal\\ nerve\\ and\\ within\\ meckel\\â\\€\\™s\\ cave\\ on\\ the\\ right\\.\\ \\ the\\ mass\\ measures\\ approximately\\ 1\\.4\\ cm\\ ap\\ x\\ 1\\.1\\ cm\\ transverse\\ x\\ 1\\.5\\ cm\\ craniocaudal\\.\\ \\ the\\ mass\\ is\\ isointense\\ to\\ brain\\ on\\ the\\ t1\\ and\\ t2\\ weighted\\ sequences\\.\\ \\ it\\ has\\ diffuse\\ homogenous\\ enhancement\\ on\\ the\\ post\\ gadolinium\\ images\\.\\ \\ the\\ mass\\ extends\\ to\\ foramen\\ ovale\\ on\\ the\\ right\\;\\ but\\ does\\ not\\ pass\\ through\\.\\ \\ there\\ is\\ minimal\\ mass\\ effect\\ on\\ the\\ adjacent\\ right\\ temporal\\ lobe\\.\\ \\ \\ \\ there\\ is\\ atrophy\\ and\\ fatty\\ infiltration\\ of\\ the\\ muscles\\ of\\ mastication\\,\\ ipsilateral\\ to\\ the\\ mass\\ lesion\\.\ \(0\)\
\-\ trigeminal\\ schwannoma\ \(7\)\
\-\ meningioma\ \(167\)\
\-\ schwannoma\ \(67\)\
\-\ epidermoid\ \(89\)\
\-\ dermoid\ \(313\)\
\-\ lymphoma\ \(373\)\
\-\ sarcoid\ \(163\)\
\-\ primary\\ melanoma\ \(3\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ vascular\\ lesions\\ \\(aneurysm\\,\\ carotid\\-cavernous\\ fistula\\)\ \(0\)\
\-\ paraganglioma\ \(36\)\
\-\ the\\ patient\\ presented\\ with\\ right\\ sided\\ facial\\ pain\\ and\\ headaches\\.\ \(0\)\
\-\ the\\ patient\\ in\\ this\\ case\\ presented\\ with\\ facial\\ pain\\ and\\ headaches\\.\\ \\ the\\ main\\ symptoms\\ of\\ trigeminal\\ schwannomas\\ are\\ facial\\ numbness\\,\\ hyperesthesia\\,\\ and\\ pain\\.\\ \\ memory\\ loss\\ and\\ seizures\\ can\\ also\\ occur\\.\\ \\ the\\ trigeminal\\ schwannoma\\ in\\ this\\ case\\ involved\\ the\\ cerebellopontine\\ angle\\ at\\ the\\ root\\ entry\\ zone\\ of\\ the\\ trigeminal\\ nerve\\ along\\ the\\ pons\\.\\ \\ the\\ tumor\\ also\\ involved\\ meckel\\â\\€\\™s\\ cave\\.\\ \\ it\\ did\\ not\\ extend\\ through\\ the\\ foramen\\ of\\ ovale\\.\\ \\ four\\ distinct\\ types\\ of\\ trigeminal\\ schwannomas\\ have\\ been\\ categorized\\.\\ \\ the\\ four\\ categories\\ include\\ those\\ confined\\ to\\ the\\ cavernous\\ sinus\\,\\ those\\ located\\ within\\ meckel\\â\\€\\™s\\ cave\\,\\ those\\ located\\ within\\ the\\ cerebellopontine\\ angle\\,\\ and\\ those\\ that\\ involve\\ both\\ the\\ posterior\\ and\\ middle\\ cranial\\ fossa\\.\\ \\ the\\ tumor\\ in\\ this\\ case\\ fits\\ into\\ the\\ last\\ category\\ where\\ it\\ is\\ a\\ giant\\ trigeminal\\ schwannoma\\ involving\\ both\\ the\\ posterior\\ and\\ middle\\ cranial\\ fossa\\.\\ \\ \ \(0\)\
\-\ trigeminal\\ schwannomas\\ are\\ uncommon\\ tumors\\ that\\ account\\ for\\ 0\\.07\\-0\\.36\\%\\ of\\ all\\ intracranial\\ tumors\\.\\ \\ the\\ peak\\ incidence\\ of\\ trigeminal\\ schwannomas\\ occurs\\ in\\ the\\ fourth\\ decade\\ of\\ life\\ which\\ is\\ consistent\\ with\\ the\\ age\\ at\\ presentation\\ for\\ the\\ patient\\ in\\ this\\ case\\.\\ \\ this\\ tumor\\â\\€\\™s\\ mri\\ signal\\ characteristics\\ were\\ very\\ typical\\ for\\ schwannomas\\.\\ schwannomas\\ are\\ typically\\ isointense\\ to\\ hypointense\\ on\\ t1\\ weighted\\ images\\,\\ hyperintense\\ on\\ t2\\ weighted\\ images\\,\\ well\\ circumscribed\\,\\ and\\ show\\ strong\\ enhancement\\.\\ \\ although\\ this\\ tumor\\ did\\ not\\ have\\ any\\ cystic\\ components\\,\\ trigeminal\\ schwannomas\\ are\\ more\\ likely\\ to\\ contain\\ cystic\\ areas\\ than\\ vestibular\\ \\(\\"acoustic\\"\\)\\ schwannomas\\.\\ \\ \\ pertinent\\ anatomy\\ for\\ the\\ trigeminal\\ nerve\\ is\\ as\\ follows\\:\ \(0\)\
\-\ the\\ trigeminal\\ nerve\\ exits\\ the\\ brainstem\\ at\\ the\\ mid\\-pons\\,\\ passes\\ through\\ the\\ cerebellopontine\\ angle\\,\\ and\\ enters\\ meckel\\â\\€\\™s\\ cave\\ where\\ the\\ trigeminal\\ ganglion\\ \\(gasserian\\ ganglion\\)\\ is\\ located\\.\\ \\ the\\ nerve\\ then\\ branches\\ into\\ three\\ segments\\.\\ \\ the\\ mandibular\\ nerve\\ \\(v3\\)\\ passes\\ anteriorly\\ through\\ meckel\\â\\€\\™s\\ cave\\ and\\ exits\\ inferiorly\\ through\\ the\\ foramen\\ of\\ ovale\\ into\\ the\\ infratemporal\\ fossa\\.\\ \\ the\\ maxillary\\ nerve\\ \\(v2\\)\\ enters\\ the\\ lateral\\ wall\\ of\\ the\\ cavernous\\ sinus\\ with\\ the\\ ophthalmic\\ nerve\\ \\(v1\\)\\.\\ \\ the\\ maxillary\\ nerve\\ then\\ exits\\ the\\ middle\\ cranial\\ fossa\\ through\\ the\\ foramen\\ rotundum\\ and\\ the\\ ophthalmic\\ nerve\\ exits\\ through\\ the\\ superior\\ orbital\\ fissure\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ trigeminal\\:\\ 0\\.12667973183090717\ \(0\)\
\-\ schwannomas\\:\\ 0\\.08805726341313977\ \(0\)\
\-\ cave\\:\\ 0\\.06256473838716926\ \(0\)\
\-\ nerve\\:\\ 0\\.05608280740414037\ \(0\)\
\-\ exits\\:\\ 0\\.04907888438824526\ \(0\)\
\-\ meckel\\:\\ 0\\.04901212403899228\ \(0\)\
\-\ ovale\\:\\ 0\\.03459350696272403\ \(0\)\
\-\ through\\:\\ 0\\.03094480715655024\ \(0\)\
\-\ foramen\\:\\ 0\\.029721821315643007\ \(0\)\
\-\ cerebellopontine\\:\\ 0\\.02958645378308384\ \(0\)\
\-\ schwannoma\\:\\ 0\\.028436164212972286\ \(0\)\
\-\ those\\:\\ 0\\.02832979773267245\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.02791286054257329\ \(0\)\
\-\ s\\:\\ 0\\.026784346088684012\ \(0\)\
\-\ located\\:\\ 0\\.025626237212520667\ \(0\)\
\-\ fossa\\:\\ 0\\.025375589294725893\ \(0\)\
\-\ enters\\:\\ 0\\.024110360097013766\ \(0\)\
\-\ entry\\:\\ 0\\.023379319312087896\ \(0\)\
\-\ angle\\:\\ 0\\.021920750706192576\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.02120140674102917\ \(0\)\
\-\ passes\\:\\ 0\\.020692255766984878\ \(0\)\
\-\ weighted\\:\\ 0\\.020304109268537155\ \(0\)\
\-\ facial\\:\\ 0\\.020304109268537155\ \(0\)\
\-\ cranial\\:\\ 0\\.020304109268537155\ \(0\)\
\-\ ganglion\\:\\ 0\\.019847805442550177\ \(0\)\
\-\ tumor\\:\\ 0\\.018144192182247828\ \(0\)\
\-\ middle\\:\\ 0\\.017077371418811136\ \(0\)\
\-\ maxillary\\:\\ 0\\.017021434235245776\ \(0\)\
\-\ zone\\:\\ 0\\.0165349810745007\ \(0\)\
\-\ root\\:\\ 0\\.016061199186529127\ \(0\)\
\-\ 0\\.07\\-0\\.36\\:\\ 0\\.01605741060831785\ \(0\)\
\-\ mid\\-pons\\:\\ 0\\.01605741060831785\ \(0\)\
\-\ gasserian\\:\\ 0\\.01605741060831785\ \(0\)\
\-\ isointense\\:\\ 0\\.01530199601867118\ \(0\)\
\-\ mastication\\:\\ 0\\.014794847437899003\ \(0\)\
\-\ v2\\:\\ 0\\.014794847437899003\ \(0\)\
\-\ cavernous\\:\\ 0\\.01443893683077188\ \(0\)\
\-\ hyperesthesia\\:\\ 0\\.014056295328412365\ \(0\)\
\-\ case\\:\\ 0\\.013621161623805252\ \(0\)\
\-\ v3\\:\\ 0\\.01353228426748016\ \(0\)\
\-\ v1\\:\\ 0\\.01353228426748016\ \(0\)\
\-\ rotundum\\:\\ 0\\.01353228426748016\ \(0\)\
\-\ four\\:\\ 0\\.013513926958345784\ \(0\)\
\-\ carotid\\-cavernous\\:\\ 0\\.013125829711352273\ \(0\)\
\-\ the\\:\\ 0\\.013094649917283319\ \(0\)\
\-\ involved\\:\\ 0\\.013057959224451408\ \(0\)\
\-\ mass\\:\\ 0\\.012988644884672836\ \(0\)\
\-\ infratemporal\\:\\ 0\\.012793732157993521\ \(0\)\
\-\ where\\:\\ 0\\.012705436266582576\ \(0\)\
\-\ cm\\:\\ 0\\.012524350370584622\ \(0\)\
\-\ headaches\\:\\ 0\\.011899607792609393\ \(0\)\
\-\ tumors\\:\\ 0\\.011692955765648456\ \(0\)\
\-\ fits\\:\\ 0\\.011689659656043948\ \(0\)\
\-\ categorized\\:\\ 0\\.011531168987574676\ \(0\)\
\-\ sinus\\:\\ 0\\.011384914279207424\ \(0\)\
\-\ did\\:\\ 0\\.01124014076864453\ \(0\)\
\-\ into\\:\\ 0\\.011111073048960148\ \(0\)\
\-\ then\\:\\ 0\\.011078203564379198\ \(0\)\
\-\ categories\\:\\ 0\\.010600703370514586\ \(0\)\
\-\ this\\:\\ 0\\.010504231839498722\ \(0\)\
\-\ it\\:\\ 0\\.01049643925974326\ \(0\)\
\-\ smoothly\\:\\ 0\\.010427096485625105\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.010427096485625105\ \(0\)\
\-\ memory\\:\\ 0\\.010346127883492439\ \(0\)\
\-\ along\\:\\ 0\\.010287992265422645\ \(0\)\
\-\ x\\:\\ 0\\.010269822715291355\ \(0\)\
\-\ category\\:\\ 0\\.010194248814386698\ \(0\)\
\-\ 1\\.4\\:\\ 0\\.009923902721275088\ \(0\)\
\-\ t1\\:\\ 0\\.009867014703913456\ \(0\)\
\-\ 1\\.1\\:\\ 0\\.009688544376138466\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.009634167394080758\ \(0\)\
\-\ mandibular\\:\\ 0\\.009634167394080758\ \(0\)\
\-\ marginated\\:\\ 0\\.009530053707669196\ \(0\)\
\-\ confined\\:\\ 0\\.009384256425932335\ \(0\)\
\-\ homogenous\\:\\ 0\\.009249269227109525\ \(0\)\
\-\ distinct\\:\\ 0\\.009249269227109525\ \(0\)\
\-\ on\\:\\ 0\\.009229940048375221\ \(0\)\
\-\ is\\:\\ 0\\.009217881612864355\ \(0\)\
\-\ decade\\:\\ 0\\.00916453331520626\ \(0\)\
\-\ strong\\:\\ 0\\.009044391297370565\ \(0\)\
\-\ not\\:\\ 0\\.008996857353311004\ \(0\)\
\-\ cystic\\:\\ 0\\.00897862552732881\ \(0\)\
\-\ pass\\:\\ 0\\.008968484746549857\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.008968484746549857\ \(0\)\
\-\ images\\:\\ 0\\.008957726185515595\ \(0\)\
\-\ vestibular\\:\\ 0\\.008931685643967855\ \(0\)\
\-\ within\\:\\ 0\\.00890782190374908\ \(0\)\
\-\ pons\\:\\ 0\\.00889561528459412\ \(0\)\
\-\ monitor\\:\\ 0\\.008860245365000128\ \(0\)\
\-\ peak\\:\\ 0\\.008860245365000128\ \(0\)\
\-\ t2\\:\\ 0\\.00881088804644937\ \(0\)\
\-\ account\\:\\ 0\\.008791501598182557\ \(0\)\
\-\ pertinent\\:\\ 0\\.008758078759078374\ \(0\)\
\-\ segments\\:\\ 0\\.008758078759078374\ \(0\)\
\-\ acoustic\\:\\ 0\\.00872525816617732\ \(0\)\
\-\ brainstem\\:\\ 0\\.00872525816617732\ \(0\)\
\-\ contain\\:\\ 0\\.008599588090609104\ \(0\)\
\-\ branches\\:\\ 0\\.008510717117622888\ \(0\)\
\-\ are\\:\\ 0\\.008487241329906024\ \(0\)\
\-\ presented\\:\\ 0\\.008485820164016063\ \(0\)\
\-\ infiltration\\:\\ 0\\.008482031585804782\ \(0\)\
\-\ follows\\:\\ 0\\.008371604223661915\ \(0\)\
\-\ fissure\\:\\ 0\\.008345012603586955\ \(0\)\
\-\ enhancement\\:\\ 0\\.008344221370211425\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.008292966387841863\ \(0\)\
\-\ inferiorly\\:\\ 0\\.00816900743839739\ \(0\)\
\-\ fatty\\:\\ 0\\.008075577029676897\ \(0\)\
\-\ anatomy\\:\\ 0\\.008052949488695919\ \(0\)\
\-\ atrophy\\:\\ 0\\.008030599593264564\ \(0\)\
\-\ sarcoid\\:\\ 0\\.007986706056690681\ \(0\)\
\-\ both\\:\\ 0\\.007949726742025943\ \(0\)\
\-\ melanoma\\:\\ 0\\.007943845405670292\ \(0\)\
\-\ types\\:\\ 0\\.007943845405670292\ \(0\)\
\-\ \\(\\:\\ 0\\.00789466367479629\ \(0\)\
\-\ extend\\:\\ 0\\.007801309527892973\ \(0\)\
\-\ \\)\\:\\ 0\\.00779822614331481\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.00778182812695172\ \(0\)\
\-\ characteristics\\:\\ 0\\.007743479476318146\ \(0\)\
\-\ residual\\:\\ 0\\.007724603725798025\ \(0\)\
\-\ fistula\\:\\ 0\\.007633052114175276\ \(0\)\
\-\ components\\:\\ 0\\.007633052114175276\ \(0\)\
\-\ anteriorly\\:\\ 0\\.007633052114175276\ \(0\)\
\-\ uncommon\\:\\ 0\\.007615281303710132\ \(0\)\
\-\ fourth\\:\\ 0\\.007528938427763713\ \(0\)\
\-\ giant\\:\\ 0\\.0074955155886595294\ \(0\)\
\-\ numbness\\:\\ 0\\.007479031370954762\ \(0\)\
\-\ epidermoid\\:\\ 0\\.007414546986526864\ \(0\)\
\-\ gadolinium\\:\\ 0\\.007383141146026852\ \(0\)\
\-\ hypointense\\:\\ 0\\.007383141146026852\ \(0\)\
\-\ orbital\\:\\ 0\\.007383141146026852\ \(0\)\
\-\ involve\\:\\ 0\\.007337024920190259\ \(0\)\
\-\ main\\:\\ 0\\.007248153947204045\ \(0\)\
\-\ posterior\\:\\ 0\\.007175368119134603\ \(0\)\
\-\ incidence\\:\\ 0\\.00713602663755116\ \(0\)\
\-\ muscles\\:\\ 0\\.007109041053243071\ \(0\)\
\-\ dermoid\\:\\ 0\\.007095696717920534\ \(0\)\
\-\ there\\:\\ 0\\.006949265335874255\ \(0\)\
\-\ circumscribed\\:\\ 0\\.00691846737186079\ \(0\)\
\-\ \\,\\:\\ 0\\.006903353219020079\ \(0\)\
\-\ life\\:\\ 0\\.0067903863182770755\ \(0\)\
\-\ extends\\:\\ 0\\.006745957441912486\ \(0\)\
\-\ have\\:\\ 0\\.00674112232555589\ \(0\)\
\-\ continued\\:\\ 0\\.006702586497115184\ \(0\)\
\-\ seizures\\:\\ 0\\.006691903219424113\ \(0\)\
\-\ measures\\:\\ 0\\.006660224270950764\ \(0\)\
\-\ last\\:\\ 0\\.006649785883502703\ \(0\)\
\-\ for\\:\\ 0\\.006640329222611249\ \(0\)\
\-\ intracranial\\:\\ 0\\.006578345604534978\ \(0\)\
\-\ right\\:\\ 0\\.0065692656401487555\ \(0\)\
\-\ recurrent\\:\\ 0\\.006568364792577554\ \(0\)\
\-\ sequences\\:\\ 0\\.0064999897118506594\ \(0\)\
\-\ hyperintense\\:\\ 0\\.006462040555379181\ \(0\)\
\-\ occurs\\:\\ 0\\.006388434838916745\ \(0\)\
\-\ at\\:\\ 0\\.006326574605637339\ \(0\)\
\-\ transverse\\:\\ 0\\.006241250809016389\ \(0\)\
\-\ typical\\:\\ 0\\.006241250809016389\ \(0\)\
\-\ temporal\\:\\ 0\\.006232952418240686\ \(0\)\
\-\ aneurysm\\:\\ 0\\.0061519838161080195\ \(0\)\
\-\ also\\:\\ 0\\.006137047700073411\ \(0\)\
\-\ minimal\\:\\ 0\\.006128378816759194\ \(0\)\
\-\ meningioma\\:\\ 0\\.0059855907767852\ \(0\)\
\-\ occur\\:\\ 0\\.00583979349504834\ \(0\)\
\-\ which\\:\\ 0\\.005811091392504731\ \(0\)\
\-\ sided\\:\\ 0\\.005755057583145074\ \(0\)\
\-\ pain\\:\\ 0\\.005702776871752649\ \(0\)\
\-\ ap\\:\\ 0\\.005692457139603712\ \(0\)\
\-\ very\\:\\ 0\\.005649882729430108\ \(0\)\
\-\ effect\\:\\ 0\\.0055110350693428865\ \(0\)\
\-\ typically\\:\\ 0\\.0054944003087540475\ \(0\)\
\-\ involving\\:\\ 0\\.005461579715852994\ \(0\)\
\-\ to\\:\\ 0\\.0054453128581072935\ \(0\)\
\-\ that\\:\\ 0\\.005376978974713382\ \(0\)\
\-\ presentation\\:\\ 0\\.005361385490876288\ \(0\)\
\-\ does\\:\\ 0\\.005310785191956296\ \(0\)\
\-\ although\\:\\ 0\\.005256701786114032\ \(0\)\
\-\ three\\:\\ 0\\.005247038667298562\ \(0\)\
\-\ areas\\:\\ 0\\.005237426541431816\ \(0\)\
\-\ available\\:\\ 0\\.005232639433223674\ \(0\)\
\-\ vascular\\:\\ 0\\.005103466790389247\ \(0\)\
\-\ superior\\:\\ 0\\.0049703892478218424\ \(0\)\
\-\ follow\\:\\ 0\\.004945718528135581\ \(0\)\
\-\ adjacent\\:\\ 0\\.004921377493869339\ \(0\)\
\-\ post\\:\\ 0\\.00490133885805518\ \(0\)\
\-\ any\\:\\ 0\\.00490133885805518\ \(0\)\
\-\ resection\\:\\ 0\\.004854126877086008\ \(0\)\
\-\ approximately\\:\\ 0\\.004815697316130388\ \(0\)\
\-\ show\\:\\ 0\\.004778061811460157\ \(0\)\
\-\ age\\:\\ 0\\.004737541576583436\ \(0\)\
\-\ diffuse\\:\\ 0\\.0047122175234523035\ \(0\)\
\-\ brain\\:\\ 0\\.004683700406744557\ \(0\)\
\-\ patient\\:\\ 0\\.00468083022358682\ \(0\)\
\-\ primary\\:\\ 0\\.004610900296713473\ \(0\)\
\-\ and\\:\\ 0\\.004590393588799742\ \(0\)\
\-\ loss\\:\\ 0\\.004518149676627395\ \(0\)\
\-\ wall\\:\\ 0\\.004508486557811924\ \(0\)\
\-\ lymphoma\\:\\ 0\\.004448449242968098\ \(0\)\
\-\ all\\:\\ 0\\.00440241072756155\ \(0\)\
\-\ likely\\:\\ 0\\.004390327806804474\ \(0\)\
\-\ include\\:\\ 0\\.004366399796047881\ \(0\)\
\-\ been\\:\\ 0\\.004234599070061915\ \(0\)\
\-\ lobe\\:\\ 0\\.0041882064625200985\ \(0\)\
\-\ up\\:\\ 0\\.004185513936346491\ \(0\)\
\-\ lesions\\:\\ 0\\.0041667768785864255\ \(0\)\
\-\ signal\\:\\ 0\\.004103960528730016\ \(0\)\
\-\ than\\:\\ 0\\.004078413214787384\ \(0\)\
\-\ metastatic\\:\\ 0\\.0039182320648744814\ \(0\)\
\-\ more\\:\\ 0\\.0038928530224265324\ \(0\)\
\-\ symptoms\\:\\ 0\\.0038791575171186507\ \(0\)\
\-\ in\\:\\ 0\\.0038378618409859286\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.003825382582207317\ \(0\)\
\-\ consistent\\:\\ 0\\.0038165724386725014\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.003751820586488603\ \(0\)\
\-\ \\;\\:\\ 0\\.0036892917822451614\ \(0\)\
\-\ \\%\\:\\ 0\\.0036308215543643125\ \(0\)\
\-\ mri\\:\\ 0\\.003576094453396393\ \(0\)\
\-\ were\\:\\ 0\\.0035342191925135176\ \(0\)\
\-\ can\\:\\ 0\\.003530459658413606\ \(0\)\
\-\ well\\:\\ 0\\.003521094632001186\ \(0\)\
\-\ lateral\\:\\ 0\\.003363694072175866\ \(0\)\
\-\ but\\:\\ 0\\.003319678143959085\ \(0\)\
\-\ surgical\\:\\ 0\\.0032718065031902615\ \(0\)\
\-\ lesion\\:\\ 0\\.003170410247723961\ \(0\)\
\-\ has\\:\\ 0\\.0029229507659276465\ \(0\)\
\-\ of\\:\\ 0\\.0025465311649833537\ \(0\)\
\-\ disease\\:\\ 0\\.0025441485268045613\ \(0\)\
\-\ as\\:\\ 0\\.0023544216865102508\ \(0\)\
\-\ \\:\\:\\ 0\\.002058788371567696\ \(0\)\
\-\ \\.\\:\\ 0\\.0018752031818270345\ \(0\)\
\-\ or\\:\\ 0\\.0018242673023018351\ \(0\)\
\-\ a\\:\\ 0\\.0014448080211970902\ \(0\)\
\-\ with\\:\\ 0\\.0010656118040973566\ \(0\)\
